These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 33102399)
1. Characteristics of NAFLD Based on Hypopituitarism. Kodama K; Ichihara A; Seki Y; Ikarashi Y; Sagawa T; Kogiso T; Taniai M; Tokushige K Can J Gastroenterol Hepatol; 2020; 2020():8814435. PubMed ID: 33102399 [TBL] [Abstract][Full Text] [Related]
2. Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population. Mikami K; Endo T; Sawada N; Igarashi G; Kimura M; Hasegawa T; Iino C; Tomita H; Sawada K; Nakaji S; Matsuzaka M; Torok NJ; Fukuda S Cytokine; 2020 Feb; 126():154927. PubMed ID: 31756645 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients. Yuan XX; Zhu HJ; Pan H; Chen S; Liu ZY; Li Y; Wang LJ; Lu L; Yang HB; Gong FY World J Gastroenterol; 2019 Apr; 25(14):1741-1752. PubMed ID: 31011258 [TBL] [Abstract][Full Text] [Related]
4. [Abdominal adipose area, serum adiponectin and leptin levels of nonalcoholic fatty liver disease in elderly males.]. Tao T; Wu L; Shen BB; Zhao YJ Zhonghua Gan Zang Bing Za Zhi; 2009 Feb; 17(2):120-3. PubMed ID: 19254460 [TBL] [Abstract][Full Text] [Related]
5. CORRELATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE FEATURES AND LEVELS OF ADIPOKINES AND INFLAMMATORY CYTOKINES AMONG MORBIDLY OBESE INDIVIDUALS. Baltieri L; Chaim EA; Chaim FDM; Utrini MP; Gestic MA; Cazzo E Arq Gastroenterol; 2018; 55(3):247-251. PubMed ID: 30540086 [TBL] [Abstract][Full Text] [Related]
6. Rapidly progressive non-alcoholic fatty liver disease due to hypopituitarism. Report of 5 cases. Yang Y; Qi ZR; Zhang TT; Kang YJ; Wang X Neuro Endocrinol Lett; 2018 May; 39(2):99-104. PubMed ID: 30183204 [TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Adams LA; Feldstein A; Lindor KD; Angulo P Hepatology; 2004 Apr; 39(4):909-14. PubMed ID: 15057893 [TBL] [Abstract][Full Text] [Related]
8. Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetes. Cernea S; Roiban AL; Both E; Huţanu A Diabetes Metab Res Rev; 2018 Nov; 34(8):e3050. PubMed ID: 30052309 [TBL] [Abstract][Full Text] [Related]
9. Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods. Magalhães GC; Feitoza FM; Moreira SB; Carmo AV; Souto FJ; Reis SR; Martins MS; Gomes da Silva MH J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():301-12. PubMed ID: 23790128 [TBL] [Abstract][Full Text] [Related]
10. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Pennell CE; de Klerk N; Oddy WH; Shipman P; Adams LA Hepatology; 2011 Mar; 53(3):800-9. PubMed ID: 21374659 [TBL] [Abstract][Full Text] [Related]
11. Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes. Hsieh CJ; Wang PW; Hu TH PLoS One; 2015; 10(6):e0127521. PubMed ID: 26042596 [TBL] [Abstract][Full Text] [Related]
12. Leptin-to-adiponectin ratio in obese adolescents with nonalcoholic fatty liver disease. Angın Y; Arslan N; Kuralay F Turk J Pediatr; 2014; 56(3):259-66. PubMed ID: 25341597 [TBL] [Abstract][Full Text] [Related]
13. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease. Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483 [TBL] [Abstract][Full Text] [Related]
15. The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study. Rotundo L; Persaud A; Feurdean M; Ahlawat S; Kim HS Clin Mol Hepatol; 2018 Dec; 24(4):392-401. PubMed ID: 30068065 [TBL] [Abstract][Full Text] [Related]
16. Metabolic parameters and nonalcoholic fatty liver disease in hypopituitary men. Hong JW; Kim JY; Kim YE; Lee EJ Horm Metab Res; 2011 Jan; 43(1):48-54. PubMed ID: 20865648 [TBL] [Abstract][Full Text] [Related]
17. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682 [TBL] [Abstract][Full Text] [Related]
18. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease]. Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662 [No Abstract] [Full Text] [Related]
19. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)? Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670 [TBL] [Abstract][Full Text] [Related]